Chronic Kidney Disease
MOH CPD Category A7: 4 points
List of authors:
- Ong Peng Seng (Main Author)
- Lau Yee Sian (Contributing Author)
- Tengku Nur Izzati bt Tengku Abdul Kadir (Contributing Author)
- Loo Yew Win (Contributing Author)
This module has been reviewed by Dr Sunita Bavanandam, Consultant Nephrologist.
Table of Contents.
Chapter 1 - Introduction to Chronic Kidney Disease
At the end of this chapter, reader should be able to understand the prevalence, risk factors and diagnosis of chronic kidney disease (CKD).
Chapter 2 - Drug therapy in retarding CKD progression
2.1 Blood Pressure and Proteinuria
2.2 Glycaemic Control
2.3 Lipid Control
At the end of this chapter, reader should be able to understand the strategies to retard the progression of CKD.
Chapter 3 - Medications in anaemia
3.1 Anaemia in Kidney Disease
3.1.1 Investigation and Evaluation for Anaemia
3.1.2 Treatment of anaemia in CKD and kidney failure
3.1.3 Treatment target and monitoring
3.1.4 Pure Red Cell Aplasia (PRCA)
3.1.5 Dispensing and storage of ESAs
At the end of this chapter, reader should be able to understand the pathophysiology and management of CKD complications – Anaemia.
Chapter 4: Management of mineral bone disorder
4.1 Definition
4.1.1 Pathogenesis of CKD-MBD
4.1.2 Treatment Targets
4.1.3 Monitoring of CKD-MBD
4.2 Pharmacological Therapy
4.2.1 Phosphate Binders
4.2.2 Vitamin D and Its Derivatives
4.2.3 Calcimimetic
4.3 Non-Pharmacological Therapy
4.3.1 Dietary Phosphate Restriction
4.3.2 Parathyroidectomy
At the end of this chapter, reader should be able to understand the pathophysiology and management of CKD complications - Mineral Bone Disorder.
References
Quiz Assessment
Feedback
